University of California, San Francisco.
Group Health Research Institute, Seattle, Washington.
JAMA. 2016 Sep 6;316(9):962-9. doi: 10.1001/jama.2016.11046.
Tuberculosis remains an important preventable disease in the United States. An effective strategy for reducing the transmission, morbidity, and mortality of active disease is the identification and treatment of latent tuberculosis infection (LTBI) to prevent progression to active disease.
To issue a current US Preventive Services Task Force (USPSTF) recommendation on screening for LTBI.
The USPSTF reviewed the evidence on screening for LTBI in asymptomatic adults seen in primary care, including evidence dating from the inception of searched databases.
The USPSTF found adequate evidence that accurate screening tests for LTBI are available, treatment of LTBI provides a moderate health benefit in preventing progression to active disease, and the harms of screening and treatment are small. The USPSTF has moderate certainty that screening for LTBI in persons at increased risk for infection provides a moderate net benefit.
The USPSTF recommends screening for LTBI in populations at increased risk. (B recommendation).
结核病仍然是美国的一种重要可预防疾病。为了减少活动性疾病的传播、发病率和死亡率,有效策略是识别和治疗潜伏性结核病感染(LTBI),以防止其发展为活动性疾病。
发布美国预防服务工作组(USPSTF)关于 LTBI 筛查的现行建议。
USPSTF 审查了在初级保健中观察到的无症状成年人中 LTBI 筛查的证据,包括从搜索数据库开始以来的证据。
USPSTF 发现,准确的 LTBI 筛查测试可用,LTBI 的治疗在预防进展为活动性疾病方面提供了适度的健康益处,并且筛查和治疗的危害较小。USPSTF 有中等确定性,即在感染风险增加的人群中筛查 LTBI 可带来适度的净收益。
USPSTF 建议在高危人群中筛查 LTBI。(B 级推荐)。